Biodesix's major customers
Medicare accounted for 32% of Biodesix's revenue in FY 2025, down from 39% a year earlier.
Get an email when Biodesix's customer concentration changes
When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.
Major customers of Biodesix
Customers that Biodesix named in its annual report as 10% or more of revenue. A missing year means the customer was below that line or not named.
| Customer | Share of revenue | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| Medicare | 32% | ▼ from 39% | 7 years | FY 2025 · filed 26 Feb 2026 |
Formerly disclosed
| Customer | Share of revenue | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| Big Ten Conference | 40% | last FY 2021 | 2 years | FY 2021 · filed 6 Mar 2023 |
| Covance Central Laboratory Services | 21% | last FY 2019 | 1 year | FY 2019 · filed 16 Mar 2021 |
| State Of Colorado | 10% | last FY 2023 | 2 years | FY 2023 · filed 1 Mar 2024 |
| UnitedHealthcare | 7% | last FY 2024 | 2 years | FY 2024 · filed 3 Mar 2025 |
| Centura Healthcare | 5% | last FY 2021 | 2 years | FY 2021 · filed 14 Mar 2022 |
About this data
US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.
All companies · Latest dependency shifts · Bulk data and API